Clinical Trial Update: MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating MA+AZA regimen for newly diagnosed acute myeloid leukemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• MA+AZA regimen

Snippet

Sponsor: Zhongnan Hospital | Conditions: Acute Myeloid Leukaemia | Phase 3 | Status: RECRUITING